GLYCO-N GLYCOprotein N-glycosylation from non-life to eukaryotes: a Doctoral Network to expand the knowledge on a ubiquitous posttranslational modification of proteins
- Coordinator
- Universita Degli Studi Di Napoli Federico Ii, Italy
- Runs
- 1 February 2024 to 31 March 2028
- Status
- Running
- EU funding
- €2.7m
- Total cost
- —
- Partners
- 17 organisations in 7 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101119499
What the project is doing
In the project's own words, from its summary on CORDIS.
The GLYCO-N training network aims at training Doctoral Candidates (DCs) to acquire the skills to develop different innovative strategies to 1) understand the diversity and structural complexity of archaeal, microalgal and viral N-glycosylation and 2) harness this knowledge for new solutions in biomedicine and biotechnology. Protein N-glycosylation, or the attachment of oligo- and polysaccharides at specific asparagine residues, is conserved throughout life, and is now observed even in the viral world.
In contrast to eukaryotes, whose well-studied N-glycosylation machineries are relatively simple, archaea, microalgae and bacteria utilize a wide variety of monosaccharides to create a wealth of structurally diverse N-glycans, and the same holds true for some recently discovered viruses. Because protein glycosylation occurs far downstream of protein synthesis the complexity and diversity in N-glycan structures are poorly understood in detail.
This holds true specifically for N-glycosylation events that are the subject of the GLYCO-N program: those in archaea, microalgae and viruses. Understanding of the how and why of N-glycosylation in archaea, microalgae and viruses will open up many possibilities ranging from drug discovery (antivirals) to biotechnology (glycoprotein and glycoprocessing enzyme engineering for materials and life sciences). The GLYCO-N network brings together a diverse group of glycobiology researchers with world-leading expertise in microbiology, (bio)organic chemistry, computational and structural biology, bioinformatics and chemical biology.
The GLYCO-N DCs will have their own individual project with one GLYCO-N expert and will, through research internships, be exposed to complementary Glycoscience. All individual PhD projects, while rooted in fundamental science, have a practical application, either in biotechnology or in biomedicine, as will be explored through secondments with our associated partners.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universita Degli Studi Di Napoli Federico Ii | Napoli | Italy | Coordinator |
| Technische Universitaet Dresden | Dresden | Germany | Associatedpartner |
| Universitaet Duisburg-Essen | Essen | Germany | Participant |
| Danmarks Tekniske Universitet | Kongens Lyngby | Denmark | Participant |
| Adaptam Therapeutics SL | San Sebastian | Spain | Associatedpartner |
| Asociacion Centro De Investigacion Cooperativa En Biociencias Cic Biogune | Derio Vizcaya | Spain | Participant |
| Atlas Molecular Pharma SL | Derio | Spain | Associatedpartner |
| Universidad Del Pais Vasco/ Euskal Herriko Unibertsitatea | Leioa | Spain | Associatedpartner |
| Universitat De Barcelona | Barcelona | Spain | Participant |
| Alga Biologics | Isneauville | France | Associatedpartner |
| Samabriva | Amiens | France | Associatedpartner |
| Universite De Rouen Normandie | Mont Saint Aignan Cedex | France | Participant |
| Innovation Acta SRL | Siena | Italy | Associatedpartner |
| Isuschem s.r.l. | Napoli | Italy | Associatedpartner |
| Universiteit Leiden | Leiden | Netherlands | Participant |
| Imperial College of Science Technology and Medicine | London | United Kingdom | Associatedpartner |
| The Francis Crick Institute Limited | London | United Kingdom | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI